In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 37 for your search:
Drug:  gefitinib
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: D7913L00077, NCT01579630
2.

Phase: Phase III
Type: Prevention, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: KROG-4-2008-0276, 4-2008-0276, NCT00955695
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ZhejiangCH06, NCT01158170
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OXFORD-COG, COG, UO-COG, EUDRACT-2007-005391-13, ISRCTN-29580179, AZ-D7913L00059, EU-21085, NCT01243398
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: C-TONG 1104, NCT01405079
6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D791LC00001, NCT01544179
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: NS 01/03/08, 2008/00196, NCT00809237
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-09-433, NCT01027676
9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GECP10-03, 2010-024178-21, NCT01513174
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000415879, MCC-13922, ZENECA-IRUSIRES0256, MCC-IRB-102794, NCT00104728
11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000582623, YONSEI-4-2006-0136, ZENECA-YONSEI-4-2006-0136, 4-2006-0136, NCT00616499
12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: C-TONG0806, NCT00891579
13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CIH-CAMS-CHL-020, CHL-020, NCT01024712
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: not specified
Sponsor: Other
Protocol IDs: C-TONG0901, NCT01024413
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Iressa combined with Pem/Cis, NCT01192243
16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AMC 2009-0677, NCT01196234
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 70 to 85
Sponsor: Other
Protocol IDs: ZhejiangCH10, NCT01291823
18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CRUK-UCL-10/0035, UCL/10/0035 v1.0, DORIC, ZENECA-ISSRECE00002, EUDRACT-2010-021531-13, CRUKE/10/044, NCT01310855
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-07-252, NCT01312337
20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CS-S10-09, NCT01391260
21.

Phase: Phase II
Type: Diagnostic, Tissue collection/Repository, Treatment
Status: Active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: P01425, 2010-023355-29, 11/H0304/8, NCT01405846
22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1200.123, 2011-001814-33, NCT01466660
23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14034, H3E-CR-JMIT(a), NCT01469000
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: SVH-1, NCT01485809
25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: 4-2011-0662, NCT01498562
1   
New Search